2591 — Guangzhou Innogen Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$24.21bn
- HK$24.22bn
Annual cashflow statement for Guangzhou Innogen Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -733 | -175 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 525 | 1.51 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 23.7 | -6.37 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -165 | -163 |
| Capital Expenditures | -12.2 | -4.33 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | -145 | 280 |
| Sale/Maturity of Investment | ||
| Change in Net Investments | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -157 | 276 |
| Financing Cash Flow Items | -11.7 | -3.26 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 352 | 255 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 30.6 | 369 |